Oct 12!!!"CALGARY, Alberta, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX), today announces the approval of its COVID-19 clinical trial of apabetalone by the Health Research Ethics Board (HREB) – Biomedical Panel at the University of Alberta. This approval allows for recruitment in the trial to commence."
And still not one patient dosed. 7 weeks later. Yes things are really moving fast. So excited.